Azathioprine Tablets
Last Updated: September 15, 2015
Status: Current
Products Affected - Description
Azathioprine tablets, Roxane
50 mg tablets, 100 count bottle (NDC 00054-4084-25) - discontinued
50 mg tablets, 100 count unit-dose (NDC 00054-8084-25) - discontinued
Reason for the Shortage
- Roxane discontinued azathioprine tablets in mid-January 2015 due to problems obtaining active ingredient.
- Valeant acquired Salix Pharmaceuticals in April 2015.
- Mylan could not provide a reason for the shortage.
- Prometheus Laboratories states the reason for the shortage was increased demand.
Available Products
Azasan tablets, Valeant (formerly Salix)
75 mg tablets, 100 count bottle (NDC 65649-0231-41)
100 mg tablets, 100 count bottle (NDC 65649-0241-41)
Imuran tablets, Prometheus Laboratories
50 mg tablets, 100 count bottle (NDC 65483-0590-10)
50 mg tablets, 100 count bottle (NDC 65483-0590-10)
Azathioprine tablets, Mylan
50 mg tablets, 50 count unit-dose (NDC 51079-0620-06)
50 mg tablets, 50 count unit-dose (NDC 51079-0620-06)
50 mg, 100 count (NDC 00378-1005-01)
Azathioprine tablets, Zydus
50 mg tablets, 100 count bottle (NDC 68382-0003-01)
50 mg tablets, 100 count bottle (NDC 68382-0003-01)
50 mg tablets, 500 count bottle (NDC 68382-0003-05)
Estimated Resupply Dates
All suppliers have product available.
Related Shortages
- Cyclosporine (Modified) Oral Presentations — Resolved
- Mycophenolate Sodium Tablets — Resolved
- Tacrolimus Capsules — Resolved
Updated
September 15, July 9, June 18, 11 and 8, May 13, April 27, March 18, February 11, January 9, 2015; December 5, October 3, August 29, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
